Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Global Primary Immunodeficiency Diseases Market USD 5.7 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.

The global primary immunodeficiency diseases market to reach nearly USD 5.7 Billion in 2020, at a CAGR of 6.3% from 2016 to 2020, due to higher incidence of PI disorders worldwide - iHealthcareAnalyst, Inc. Visit Primary Immunodeficiency Diseases Market – Disease Types (Antibody Deficiency... - January 10, 2017 - iHealthcareAnalyst, Inc.

Makers Nutrition Wins Both Silver and Bronze Honors in Best in Biz Awards 2016

Makers Nutrition Wins Both Silver and Bronze Honors in Best in Biz Awards 2016

Nutraceutical Company recognized for its outstanding products, work environment, executive team and website. - December 22, 2016 - Makers Nutrition, LLC

Strathmore’s Who’s Who Honors John T. Spitznagel as a 2016 Professional of the Year

Strathmore’s Who’s Who Honors John T. Spitznagel as a 2016 Professional of the Year

John T. Spitznagel has recently been recognized as a 2016 Professional of the Year by Strathmore’s Who’s Who for his outstanding contributions and achievements in the field of Healthcare Sales and Marketing. - December 17, 2016 - Strathmore Who's Who

Joyce L. Morrison Has Been Recognized as Strathmore’s Who’s Who’s Woman of the Month

Joyce L. Morrison Has Been Recognized as Strathmore’s Who’s Who’s Woman of the Month

Joyce L. Morrison, of St. Joseph, Missouri, has recently been honored as Strathmore’s Who’s Who Woman of the Month for January, 2017. This honor has been bestowed in recognition of her outstanding contributions and achievements in field of Animal Health. - December 17, 2016 - Strathmore Who's Who

Bioscience Americas Lauds Passage of the 21st Century Cures Act

Bioscience Americas Lauds Passage of the 21st Century Cures Act

President Obama is expected to sign this landmark bi-partisan legislation soon. - December 13, 2016 - Bioscience Americas

Global Infusion Pump Systems, Accessories and Software Market New Report by Data Bridge Market Research

Global Infusion Pump Systems, Accessories and Software Market, By Type (Infusion Pump Systems (Volumetric IP, Syringe IP, Ambulatory IP, Enteral IP, Insulin IP, Implantable IP, Chemotherapy IP, Anesthesia IP), Infusion Pump Accessories (Infusion Administration Sets, Valve Catheters, IV Sets, Needleless Connectors), Infusion Pump Management Software, By Application, By End-User, By Distribution Channel, By Geography – Trends and Forecast to 2024 - December 10, 2016 - Data Bridge Market Research

Gatekeeper Innovation's Safer Lock Locking Prescription Bottles Now Sold at Lowe's

Retail giant Lowe's is helping prevent prescription drug abuse by carrying Safer Lock locking prescription bottles; $14.99. Look for Safer Lock in the Child Safety Area of the Hardware Department in 58 Lowe's stores in California, Oregon, and Washington. Safer Lock is also sold online nationwide... - December 09, 2016 - Gatekeeper Innovation

CrowdReviews.com Partners with Conference Series LLC Announces Asia Pharma 2017

Conference Series LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe, invites participants from all over the world to attend “10th Asia-Pacific Pharma Congress” during May 08-10, 2017 in Singapore city,... - December 06, 2016 - topseos.com

Agenda Released for Controlled Release Delivery: FDA, Janssen, GSK and Boehringer Ingelheim to Present Next April

SMi is thrilled to announce the release of the highly anticipated brochure for 14th annual Controlled Release Delivery taking place on 3rd to 4th of April in London. - December 02, 2016 - SAE Media Group

New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs

New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC

North America Drug Delivery Market New Report by Data Bridge Market Research

North America Drug Delivery Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical (Formulations, Transdermal Devices), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Centers, Others), By Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, Online Pharmacies), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2024 - December 01, 2016 - Data Bridge Market Research

The Changing Face of Pharma Industry: Great Start to the Highly Anticipated Pharma 2016 Forum by Marcus Evans

Exciting round of presentations and case studies to commence the forum. - November 30, 2016 - Marcus Evans Group

Pharma Cold Chain Distribution: Big Pharma, MHRA and Leading Logistics Companies to Meet in London This December at SMi's Cold Chain Distribution

SMi Group reports: World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016. - November 30, 2016 - SAE Media Group

Hot Topic: Pharmaceutical Water Systems Discussed at Pharmaceutical Microbiology 2017

SMi Group will return to London with their 6th annual Pharmaceutical Microbiology conference taking place on the 18-19 January 2017. - November 26, 2016 - SAE Media Group

Therapeutic Assessment Market Review and Pipeline Landscape for Lung Transplant Rejection H2 2016

This research study provides comprehensive data on the therapeutic evelopment for lung transplant rejection along with the analysis based on various stages of development, drug profiles, route of administration (RoA), mechanism of action (MoA) and molecule type. - November 25, 2016 - Market Research Hub

Forum for Drug Sponsors and Contract Development and Manufacturing Professionals Completes 2016 Program and Returns to Boston, San Diego and San Francisco in 2017

Outsourced Pharma’s final program in 2016 was recently concluded in San Francisco. For the first time, technology companies, venture capital firms and others from Silicon Valley and elsewhere were invited to join the Outsourced Pharma community to focus on the topic of “Drug Development... - November 25, 2016 - Outsourced Pharma Events

Platelet Rich Plasma (PRP) Market Size, Share, Growth, Trends and Forecast Report to 2023: Credence Research

CredenceResearch.com has announced the addition of "Platelet Rich Plasma (PRP) Market Size, Share, Growth, Trends and Forecast Report To 2023: Credence Research" Market Research Report to their Database. - November 24, 2016 - Credence Research

Mayne Pharma Launches Temozolomide Capsules in U.S. – Generic Alternative to Temodar®

Mayne Pharma Inc. (Mayne Pharma) is pleased to announce the U.S. launch of temozolomide capsules, 5mg, 20mg, 100mg, 140mg, 180mg and 250mg, which is a generic version of branded Temodar®. Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed cancerous... - November 23, 2016 - Mayne Pharma USA

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma

Pharma Cold Chain Distribution Updates from MHRA, IATA, GSK, Teva, J&J, World Courier, Finnair

SMi Group reports: World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016 - November 17, 2016 - SAE Media Group

Novartis Explore Novel Approaches to Disease Modelling and Organoid Technology

Novartis to present case studies at 3D Cell Culture in London in February. - November 12, 2016 - SAE Media Group

Erythropoietin Drugs Market is Expected to Reach $11.9 Billion, Globally, by 2020

A new report by Allied Market Research titled, "Erythropoietin Drugs Market - Global Opportunity Analysis and Industry Forecast, 2013- 2020" forecasts the Global EPO market to reach $11.9 billion by 2020, with promising CAGR of 9.7% from 2014 to 2020. Darbepoetin alfa is a fastest growing... - November 10, 2016 - Allied Market Research

Global Drug Delivery Devices Market New Report by Data Bridge Market Research

Global Drug Delivery Devices Market, By Product Type (Oral Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022 - November 10, 2016 - Data Bridge Market Research

ALFA to Feature Breakthrough Technology for Rapid Diagnostic Tests at MEDICA 2016

ALFA to Feature Breakthrough Technology for Rapid Diagnostic Tests at MEDICA 2016

ALFA Scientific Designs, Inc., a rapid immunoassay, point-of-care (POC) test development and manufacturing company based in San Diego, California, will exhibit at the MEDICA 2016 World Forum for Medicine in Düsseldorf Germany from November 14-17, 2016. ALFA will welcome visitors and customers... - November 08, 2016 - Alfa Scientific Designs

Marcus Evans: Industry Experts from Takeda, Sanofi, Amgen, Abbott and Menarini to Give In-Depth Insights

This forum highlights the way Pharma companies reengineer their business growth strategies to expand to broad markets; cultivate modern sales force with smarter marketing techniques and technology; and keeping mature brands alive in the every changing Pharma environment. - November 05, 2016 - Marcus Evans Group

NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis

NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Therapeutics

Global Albumin Market USD 300 Million by 2020, Research Study Published by iHealthcareAnalyst, Inc.

The global albumin market is estimated to reach USD 300 Million in 2020, expanding at a CAGR of 2.4% from 2016 to 2020. - November 01, 2016 - iHealthcareAnalyst, Inc.

Nanomedicine Market USD 170 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global nanomedicine market is estimated to reach USD 170 Billion in 2020, growing at a CAGR of 8.9% from 2016 to 2020, according to a market research report Nanomedicine Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Nanomedicine Market 2013-2020 report at... - November 01, 2016 - iHealthcareAnalyst, Inc.

Radiopharmaceuticals Market USD 350 Million by 2020 - iHealthcareAnalyst, Inc.

Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report... - November 01, 2016 - iHealthcareAnalyst, Inc.

Opioid Induced Constipation Drugs Market USD 2.14 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global opioid induced constipation drugs market is estimated to reach USD 2.14 Billion in 2020, growing at a CAGR of 31.3% from 2016 to 2020, according to a market research report Opioid Induced Constipation Drugs Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Opioid Induced... - October 29, 2016 - iHealthcareAnalyst, Inc.

Menopausal Hot Flashes Therapy Market USD 4.7 Billion by 2020 - iHealthcareAnalyst, Inc.

Menopausal Hot Flashes Therapy Market 2013-2020 report estimates the global menopausal hot flashes therapy market to reach nearly USD 4.7 Billion in 2020, at a CAGR of 3.8% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Menopausal Hot Flashes Therapy Market 2013-2020 report... - October 29, 2016 - iHealthcareAnalyst, Inc.

Mayne Pharma Launches Budesonide Capsules in the United States

Mayne Pharma announces the U.S. launch of budesonide capsules in a 3 mg dose. Budesonide is a generic alternative to Entocort EC®, which is used as a treatment for patients with mild to moderate Crohn’s disease. The capsules reflect the company's focus on developing and manufacturing controlled-release and potent pharmaceuticals. - October 29, 2016 - Mayne Pharma USA

Safer Lock Locking Prescription Bottles Now Sold Nationwide Thru Precision Disposables

Precision Disposables is helping prevent prescription drug abuse nationwide by carrying Safer Lock locking prescription bottles. "We believe Safer Lock is truly innovative and saves lives," says Bruce Capagli, COO for Precision Disposables. "Precision is always seeking... - October 28, 2016 - Gatekeeper Innovation

Janssen Explores How to Embed Social Media Into Multi-Channel Campaigns

Janssen Digital and Multi-channel Marketing Manager joins speaker lineup for Social Media in the Pharmaceutical Industry in London. - October 28, 2016 - SAE Media Group

Makers Nutrition Hires Pat Gillespie as New VP of Sales

Makers Nutrition Hires Pat Gillespie as New VP of Sales

Seasoned sales executive with high-level expertise helps expand Nutraceutical Company. - October 27, 2016 - Makers Nutrition, LLC

Hyaluronic Acid Injections Market USD 10.5 Billion by 2020, Research Study Published by iHealthcareAnalyst, Inc.

According to a market research report Hyaluronic Acid Injections Market 2013-2020 published by iHealthcareAnalyst, Inc., the global hyaluronic acid injections market is estimated to reach USD 10.5 Billion in 2020, expanding at a CAGR of 8.8% from 2016 to 2020. Visit the Hyaluronic Acid Injections... - October 27, 2016 - iHealthcareAnalyst, Inc.

Heparin Anticoagulant Market USD 10.8 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global heparin anticoagulant market is estimated to reach USD 10.8 Billion in 2020, growing at a CAGR of 4.4% from 2016 to 2020, according to a market research report Heparin Anticoagulant Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Heparin Anticoagulant Market 2013-2020... - October 27, 2016 - iHealthcareAnalyst, Inc.

Chemotherapy-Induced Nausea and Vomiting Drugs Market USD 1.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.

According to a market research report, Chemotherapy-induced Nausea and Vomiting Drugs Market 2013-2020, published by iHealthcareAnalyst, Inc., the global chemotherapy-induced nausea and vomiting drugs market is estimated to reach USD 1.8 Billion in 2020, expanding at a CAGR of 8.4% from 2016 to... - October 26, 2016 - iHealthcareAnalyst, Inc.

Fragment-Based Drug Discovery Market USD 650 Million by 2020, Published by iHealthcareAnalyst, Inc.

The global fragment-based drug discovery market is estimated to reach USD 650 Million in 2020, growing at a CAGR of 10.6% from 2016 to 2020, according to a market research report Fragment-based Drug Discovery Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Fragment-based Drug... - October 26, 2016 - iHealthcareAnalyst, Inc.

Exocrine Pancreatic Insufficiency Diagnostics Market USD 2.3 Billion by 2020 - iHealthcareAnalyst, Inc.

Exocrine Pancreatic Insufficiency Diagnostics Market 2013-2020 report estimates the global exocrine pancreatic insufficiency diagnostics market to reach nearly USD 2.3 Billion in 2020, at a CAGR of 8.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Exocrine Pancreatic Insufficiency... - October 26, 2016 - iHealthcareAnalyst, Inc.

Anxiety Disorders and Depression Treatment Market USD 17.8 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global anxiety disorders and depression treatment market is estimated to reach USD 17.8 Billion in 2020, growing at a CAGR of 0.9% from 2016 to 2020, according to a market research report Anxiety Disorders and Depression Treatment Market 2013-2020, published by iHealthcareAnalyst, Inc. - October 25, 2016 - iHealthcareAnalyst, Inc.

Acute Ischemic Stroke Diagnosis and Treatment Market USD 1.7 Billion by 2020 - iHealthcareAnalyst, Inc.

Acute Ischemic Stroke Diagnosis and Treatment Market 2013-2020 report estimates the global acute ischemic stroke diagnosis and treatment market to reach nearly USD 1.7 Billion in 2020, at a CAGR of 5.5% from 2016 to 2020 - iHealthcareAnalyst, Inc. - October 25, 2016 - iHealthcareAnalyst, Inc.

New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories

5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC

Non-Alcoholic Steatohepatitis (NASH) Market is Expected to Reach $1.6 Billion, Globally, by 2020

A new report by Allied Market Research entitled, "Non-Alcoholic Steatohepatitis (NASH) Market- Global Opportunity Analysis and Industry Forecast, 2013- 2020," indicates that the global nonalcoholic Steatohepatitis (NASH) market would reach $1.6 billion by 2020 registering CAGR of 25.6%... - October 23, 2016 - Allied Market Research

New Global Radiotherapy Market Report by Data Bridge Market Research

Global Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography – Trends and Forecast to 2022 - October 20, 2016 - Data Bridge Market Research

Regenerative Medicine Market to Reach $30,237 Million, Globally by 2022

The prominent potential of regenerative medicine to replace, repair, and regenerate damaged tissues and organs has boosted the market growth. - October 16, 2016 - Allied Market Research

Oncology Drugs Market is Expected to Reach $111.9 Billion, by 2020

The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars. - October 16, 2016 - Allied Market Research

Global Self-Injections Market New Report by Data Bridge Market Research

Global Self-Injections Market, By Product (Devices (Needle-Free Injectors, Auto Injectors, Pen Injectors, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), By Route Of Administration, By End-User, By Distribution, By Geography - Trends and Forecast to 2022 - October 15, 2016 - Data Bridge Market Research

Japanese Biologics Company Expands to Texas

Japanese Biologics Company Expands to Texas

ORTHOReBIRTH Co Ltd., a leading manufacturer of novel biologic products, announced the formation of ORTHOReBIRTH USA, previously Siena Biologics (Austin). The U.S. introduction of ORTHOReBIRTH’s products signals a new high-quality resource for doctors and patients throughout the... - October 14, 2016 - ORTHOReBIRTH USA

Press Releases 1,101 - 1,150 of 2,730